Cardiac Dimensions key facts
as of Oct 2026- Developer of novel interventional tools designed for the treatment of heart failure and related conditions of mitral valve regurgitation.
- Cardiac Dimensions is valued at approximately $118.3M as of Oct 2026 (last reported valuation).
- It has raised $361.1M across 4 recorded rounds; the latest was Seed Round ($1.2M) in Dec 2013.
- Notable investors include Mitsubishi UFJ Capital, Johnson & Johnson JJDC, Polaris Partners, Claret Capital Partners, EQT Life Sciences — 21 tracked in total.
- Cardiac Dimensions has filed 7 Form Ds with the SEC since 2010, most recently Mar 2014 ($1.2M sold to 10 investors).
- Status: Privately Held (backing).
Cardiac Dimensions's last reported valuation, Sep 2012. Nothing priced has surfaced since.
- ·The complete investor list: 21 names
- ·Watch Cardiac Dimensions: the Monday email on marks, rounds and moves
Cardiac Dimensions funding rounds
4 roundsWho backs Cardiac Dimensions
21+Cardiac Dimensions valuation
Cardiac Dimensions's last reported valuation was $118 million in Sep 2012. No priced round, secondary trade or fund mark has surfaced since.
How much has Cardiac Dimensions raised?
Cardiac Dimensions has raised $361 million in total; 4 of its rounds are on record, from 2012 on. The largest on record was a $5.8 million early-stage round in Aug 2012; the most recent was a $1.2 million seed round in Dec 2013.
Cardiac Dimensions has filed 7 Form Ds with the SEC since 2010, most recently in Mar 2014 ($1.2 million sold to 10 investors).
Cardiac Dimensions investors
21 investors are on record for Cardiac Dimensions, including Mitsubishi UFJ Capital, Johnson & Johnson JJDC, Polaris Partners and Claret Capital Partners. By type, the record holds 8 venture capital firms, 2 growth equity firms and 1 corporate investor. The seed round in Dec 2013 drew 10 investors.
About Cardiac Dimensions
Developer of novel interventional tools designed for the treatment of heart failure and related conditions of mitral valve regurgitation. The company's product is a non-surgical device developed to treat functional mitral valve regurgitation and uses a catheter-based approach to reshape the mitral valve and reduce mitral regurgitation, enabling surgeons to perform minimally invasive treatments to address heart failure and related cardiovascular conditions.
- Sector
- Healthcare
- HQ
- Kirkland, WA, United States
- Founded
- 2001
- Employees
- 73
- Website
- cardiacdimensions.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.